±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 425  |  »Ø¸´: 1
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

lmljyt

Í­³æ (³õÈëÎÄ̳)

[½»Á÷] ×¢ÉäÓÃÁ×Ëá·ú´ïÀ­±õµÄÓйØÎïÖʲⶨ

Ïò¸÷λÀÏʦÇë½Ì¹ØÓÚ×¢ÉäÓÃÁ×Ëá·ú´ïÀ­±õµÄÓйØÎïÖʲⶨ·½·¨¼°ÆäÏÞ¶È
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

shich68

ľ³æ (ÖøÃûдÊÖ)

USP29ÖеĶÔÓйØÎïÖʵÄÃèÊö,¹©²Î¿¼:

Related compounds¡ª
TEST A (EARLY-ELUTING IMPURITIES)¡ª
Mobile phase¡ª Prepare as directed in the Assay.
Standard solution¡ª Prepare as directed for Standard preparation in the Assay under Fludarabine Phosphate.
System suitability solution¡ª Prepare as directed for System suitability solution in Chromatographic purity Test A under Fludarabine Phosphate.
Sensitivity check solution¡ª Dilute the Standard solution with Mobile phase to obtain a solution having a concentration of 0.0005 mg per mL.
Test solution¡ª Inject 2.0 mL of water into each of 5 vials of Fludarabine Phosphate for Injection. Quantitatively transfer the contents of the vials into a single 250-mL volumetric flask, using water rinses. Dilute the volumetric flask with Mobile phase to volume, and mix to obtain a solution having a concentration of about 1 mg of fludarabine phosphate per mL.
Chromatographic system¡ª Proceed as directed for Chromatographic system in Chromatographic purity Test A under Fludarabine Phosphate.
Procedure¡ª Separately inject equal volumes (about 10 µL) of the Standard solution and the Test solution, record the chromatograms, and measure all of the peak responses up to and including the fludarabine phosphate peak. Calculate the percentage of each early-eluting impurity present in the portion of Fludarabine Phosphate taken by the formula:
100F 1 ( r u / r s ),
in which F 1 is a relative response factor equal to the values given in Table 1, and equal to 1.0 for any other individual early-eluting degradation product not appearing in Table 1; r U is the response for each individual impurity in the Test solution; and r S is the response for the fludarabine phosphate peak in the Test solution. In addition to meeting the limits for the individual degradation products given in Table 1, not more than 0.2% of any other early-eluting fludarabine phosphate degradation peak is found.
Table 1
Relative
Retention Time Relative Response
Factor ( F 1 ) Relative Response
Factor ( F 2 ) Impurity Name Limit
(w/w%)
0.26 4.0  Iso-ara-guanine-monophosphate 1.0
0.34 2.5  Isoguanine 0.2
1.5  0.5 2-fluoroadenine 0.2
1.9  0.6 2-fluoro-ara-adenine 0.2

TEST B (LATE-ELUTING-IMPURITIES)¡ª
Mobile phase¡ª Prepare a mixture of filtered, degassed 10 mM monobasic potassium phosphate and methanol (4:1).
Standard solution, System suitability solution, and Sensitivity check solution¡ª Prepare as directed for Chromatographic purity Test A under Fludarabine Phosphate.
Test solution¡ª Prepare as directed for Related compounds Test A.
Chromatographic system¡ª Proceed as directed for Chromatographic purity Test B under Fludarabine Phosphate.
Procedure¡ª Separately inject equal volumes (about 10 mL) of the Standard solution and the Test solution, record the chromatograms at 260 nm, and measure all of the peak responses starting with the fludarabine phosphate peak. Calculate the percentage of each late-eluting impurity present in the portion of Fludarabine Phosphate taken by the formula:
100F 2 ( r U / r S ),
in which F 2 is a relative response factor equal to the values given in Table 1, and 1.0 for any other individual late-eluting degradation peak not appearing in Table 1 ; r U is the response for each individual impurity in the Test solution; and r S is the response for the fludarabine phosphate peak in the Test solution. In addition to meeting the limits for the individual degradation products given in Table 1, not more than 0.2% of any other late-eluting fludarabine phosphate degradation product is found; and the sum of all fludarabine phosphate degradation products found in Test A and Test B is not more than 2.0%.
2Â¥2006-09-02 11:41:22
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ lmljyt µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 328Çóµ÷¼Á +3 ÅôÅôÅöàØàØ 2026-03-24 3/150 2026-03-31 10:56 by sophie2180
[¿¼ÑÐ] 070300»¯Ñ§279Çóµ÷¼Á +7 ¹þ¹þ¹þ^_^ 2026-03-31 9/450 2026-03-31 10:02 by cal0306
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á +5 ÕâÊÇÓÐÌ«ÑôÍÛ 2026-03-25 5/250 2026-03-31 09:59 by luoyongfeng
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷½»288»¯¹¤×¨Ë¶Çóµ÷¼Á +4 ºÃÔ˺ÃÔË½Ó½Ó 2026-03-24 4/200 2026-03-31 09:18 by Î÷¾©Ñ§ÔºÍÁľ¹¤³
[¿¼ÑÐ] 08¹¤¿ÆÇóµ÷¼Á286 +5 tgs_001 2026-03-28 5/250 2026-03-31 08:18 by Ò»Ö»ºÃ¹û×Ó?
[¿¼ÑÐ] Ò»Ö¾Ô¸Ö£´ó²ÄÁϹ¤³Ì290Çóµ÷¼Á +12 Youth_ 2026-03-30 12/600 2026-03-31 03:34 by ÃÉÆæÆæ521
[¿¼ÑÐ] 297 µØÀíѧ070500 ¸´ÊÔÇóµ÷¼Á +3 СԲȦȦooo 2026-03-30 3/150 2026-03-30 21:05 by ÓàÕðyz
[¿¼ÑÐ] 085600 286·Ö ²ÄÁÏÇóµ÷¼Á +11 ÂéÀ±öÏÓã 2026-03-27 12/600 2026-03-30 19:33 by Wang200018
[¿¼ÑÐ] ¿¼Ñе÷¼Á +5 Sanmu-124 2026-03-26 5/250 2026-03-30 13:36 by chemdavid
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖÐÄÏ´óѧ»¯Ñ§0703×Ü·Ö337Çóµ÷¼Á +6 niko- 2026-03-27 6/300 2026-03-30 10:25 by herarysara
[¿¼ÑÐ] 318Ò»Ö¾Ô¸¼ªÁÖ´óѧÉúÎïÓëÒ½Ò© Çóµ÷¼Á +5 óÆÐÐÖÂÔ¶. 2026-03-28 5/250 2026-03-30 06:56 by ilovexiaobin
[¿¼ÑÐ] 070305¸ß·Ö×Ó»¯Ñ§ÓëÎïÀí 304·ÖÇóµ÷¼Á +12 c297914 2026-03-28 12/600 2026-03-29 16:21 by Serene1974
[¿¼ÑÐ] 321Çóµ÷¼Á +7 è±Óñ~~ 2026-03-25 8/400 2026-03-29 06:41 by 544594351
[¿¼ÑÐ] 339Çóµ÷¼Á£¬Ïëµ÷»Ø½­ËÕ +6 ¿¾ÂóÑ¿ 2026-03-27 8/400 2026-03-28 10:40 by ¿¾ÂóÑ¿
[¿¼ÑÐ] 086502»¯Ñ§¹¤³Ì342Çóµ÷¼Á +6 °¢Ò̸´¹Å²»¹ý 2026-03-27 6/300 2026-03-28 07:06 by wangy0907
[¿¼ÑÐ] 086000µ÷¼Á +3 7901117076 2026-03-26 3/150 2026-03-27 21:34 by Jianing_Mi
[¿¼ÑÐ] 314Çóµ÷¼Á +3 ÏªÔÆçæ 2026-03-26 3/150 2026-03-27 11:20 by sanrepian
[¿¼ÑÐ] 286Çóµ÷¼Á +4 lim0922 2026-03-26 4/200 2026-03-27 10:28 by guoweigw
[¿¼ÑÐ] »úеѧ˶310·Ö£¬ÊýÒ»Ó¢Ò»£¬Ò»Ö¾Ô¸211±¾¿ÆË«·ÇÕÒµ÷¼ÁÐÅÏ¢ +3 @357 2026-03-25 3/150 2026-03-26 16:34 by by.MENG
[¿¼ÑÐ] 080500Çóµ÷¼Á +3 zzzzfan 2026-03-24 3/150 2026-03-24 16:38 by barlinike
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û